Duke's McClellan: Changing Drug Development Policy From Outside FDA

In an interview, Margolis Center for Health Policy's Mark McClellan and Gregory Daniel talk about their recent move from Brookings to Duke, the breadth and impact of their work with FDA on drug development issues, and opportunities for potential future collaborations under PDUFA VI.

Mark McClellan, the former FDA commissioner and Centers for Medicare and Medicaid Services administrator, has had a unique role in helping to inform and shape drug development and FDA oversight of medical products since leaving government service 10 years ago.

Starting in 2007, when he was named director of a new health care group within the Brookings Institution, McClellan has...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Approval Standards

More from Pathways & Standards